Skip to main content

Table 5 Mean levels of health-related quality of life for patients with fibromyalgia and matched controls as a function of sleep difficulty symptoms

From: The association of sleep difficulties with health-related quality of life among patients with fibromyalgia

 

Matched control

Patients with FM

No symptoms (n=717)

One symptom (n=636)

Two or more symptoms (n=841)

No symptoms (n=269)

One symptom (n=572)

Two or more symptoms (n=1353)

p (Main effect)

p (Interaction)

Mental component summary

51.20

47.65

43.51

47.26

42.34

40.00

<.0001

<.0001

Physical component summary

46.56

43.51

41.68

35.91

33.24

31.57

<.0001

0.0445

Health utilities

0.77

0.71

0.66

0.64

0.59

0.55

<.0001

<.0001

Bodily pain

75.45

66.86

59.69

46.00

37.94

31.04

<.0001

0.0028

General health

67.34

59.82

54.99

52.86

43.75

39.49

<.0001

0.0097

Vitality

53.66

46.74

37.57

36.52

28.54

25.67

<.0001

<.0001

Social functioning

83.05

73.86

63.59

63.66

52.01

44.92

<.0001

0.0003

Mental health

74.01

64.94

56.79

64.73

55.75

49.06

<.0001

<.0001

Emotional role limitations

83.26

76.47

69.59

69.80

58.26

55.14

<.0001

0.0545

Physical role limitations

73.34

63.38

56.45

48.19

36.39

31.88

<.0001

0.0069

Physical functioning

74.23

64.98

58.95

46.47

39.51

34.59

<.0001

0.0151

  1. The p-value for the main effect represents the significance of the HRQoL differences between patients with FM and matched controls across all levels of symptoms. The p-value for the interaction represents the significance of whether the change from no symptoms to one symptom to two or more symptoms was different between patients with FM and matched controls.
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us